Baxter price target raised to $56 from $54 at Stifel

Stifel analyst Rick Wise raised the firm’s price target on Baxter to $56 from $54 and keeps a Buy rating on the shares ahead of the company’s Q2 report due on July 27. The firm argues that the stage is set positively for Baxter to “regress to the mean” fundamentally with possible early signs of more-consistent performance as well as several growth-accelerating and margin-improving catalysts.